Equity
-€4,334
Debts exceed assets in financial year 2026.
KANEKA EUROGENTEC
Lifetime
20 annual accounts with figures on one time axis, 41 filings since 1985Turnoverpeak €98.4m (2023)
€49.4m▼ 26.9%
Resultlowest -€36.3m (2025)
-€20.4m▲ €15.9m
Equitypeak €67.9m (2023)
-€4,334▼ €20.8m
Debts
€115.3m▲ 9.5%
Staffpeak 418.9 FTE (2024)
379.2 FTE▼ 6.4%
Board9 names since 2017
5 directorsLieven JANSSENS and 4 others
Owners4 names in the annual accounts
consolidatesKaneka Corporation
Documentsfilings and deeds
17-07-2026106 days before the deadline
2026financial year
Turnover from €67.6m to €49.4mLoss of €20.4mAdmissions: Anne Gregov, Kotaro Oshima, Gottfried Proess, Pat… 28-09Resignation: Kan OKABE (director) 28-09Equity from €20.8m to -€4,334
Key points
from the 2026 annual accountsLosses
-€61.8m in three years
Every financial year from 2024 to 2026 closed with a loss. 2025 was the heaviest.
Debts
€115.3m 100% of the balance sheet
Financial debts 56%Suppliers 13%Taxes and wages 5%Other 26%
Of this, €51.5m falls due within a year.
Payment terms
147 days to suppliers
KANEKA EUROGENTEC pays its suppliers 7 days later than in 2025. Customers pay 27 days later.
Filings
41 annual accounts 59 filings since 1985
The last five annual accounts were filed 99 to 106 days before the end of the period.
Board
1 joined · 1 left
Board changed. Latest change 24-06-2026 · 5 in office.
Standalone figures, without subsidiaries
Checked score
49
Fair
Financially stronger than 12% of all companies
Probability in this band: 1.5% to 4.2%
Bankruptcy probability within 12 months
2.7% Moderate
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.1% across 16 companies (NACE 72, large).
About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.3%
01-2025: 0.3%● unchanged vs 12-2024
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025
05-2025: 0.3%● unchanged vs 04-2025lowest value
06-2025: 0.3%● unchanged vs 05-2025
07-2025: 0.3%● unchanged vs 06-2025
08-2025: 1.4%▲ +1.1 percentage points vs 07-2025
09-2025: 1.4%● unchanged vs 08-2025
10-2025: 1.4%● unchanged vs 09-2025
11-2025: 1.4%● unchanged vs 10-2025
12-2025: 1.4%● unchanged vs 11-2025
01-2026: 1.4%● unchanged vs 12-2025
02-2026: 1.4%● unchanged vs 01-2026
03-2026: 1.4%● unchanged vs 02-2026
04-2026: 1.4%● unchanged vs 03-2026
05-2026: 1.4%● unchanged vs 04-2026
06-2026: 1.4%● unchanged vs 05-2026
07-2026: 1.4%● unchanged vs 06-2026
08-2026: 2.7%▲ +1.3 percentage points vs 07-2026highest value
09-2026: 2.7%● unchanged vs 08-2026highest value
10-2026: 2.7%● unchanged vs 09-2026highest value
11-2026: 2.7%● unchanged vs 10-2026highest value
Financial strengthWeak
Score breakdown
raises risk
Negative equity -€4,334
Loss of €20.4m, the second in a row (financial year 2026)
Liquidity: current ratio 0.70, cash €628,642
Founded in 1985
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (all companies). It does better than 10% of them on solvency, 26% on liquidity, 4% on profitability and 9% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-03-2026.
Of the companies with a bankruptcy probability in the moderate class on 30-06-2025, 2.4% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 7,425 companies had the same profile as KANEKA EUROGENTEC has now. Each dot stands for 19 companies, two years later.
84.4%
were still trading
9.6%
stopped another way
4.8%
went bankrupt
Another 1.2% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of KANEKA EUROGENTEC itself: 2.7% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,425 companies, not a prediction for KANEKA EUROGENTEC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
No credit on open account
Liquidity is insufficient, with a current ratio of 0.7 (0.69 in 2025), below 1. Short-term debt is 44.6% and cash 0.5% of total assets. Equity is negative.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
raises riskneutral
raises risk · Negative equity
The 2026 annual accounts show negative equity and a net loss.
NBB · annual accounts 2026Equity per financial year
1920212223242526
2019 to 2026 · latest year -€4,334
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 17-07-2026, 106 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2026
106 days early
2025
106 days early
2024
100 days early
2023
99 days early
2022
103 days early
2021
18 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 6 accounts on average 83 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 20 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
05-11-2026 today31-03-2027 year end31-10-2027 deadline
Board and ownership
KR
KPMG Réviseurs d'Entreprises BV/SRL
Auditor, Grégory Gonzalez Rodriguez
- Kaneka Europe Holding Company 100%equity €192.9m (2026) · 31-03-2025 annual accounts of Kaneka Europe Holding Company
- Kaneka Corporation consolidatesannual accounts 31-03-2026
Shares in 7 companies, including EUROGENTEC FRANCE and EUROGENTEC LTD
Board & ownershipRecent changes
Admissions: Anne Gregov, Kotaro Oshima, Gottfried Proess, Patrick Stragier, Vincent Vaerman, Isabelle Bechet and 5 others
Board meeting of 03-04-2019 · Gazette deed
Resignation: Kan OKABE (director)
Appointment: Hiroyuki NISHIMOTО (director) · Director discharge: Kan OKABE · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0427348346
Resignations & appointments
Gazette deed
Comparable companies
same main activity, similar in size and age| Company | Turnover | EBIT margin | Solvency | Staff |
|---|---|---|---|---|
| KANEKA EUROGENTEC Seraing | €49.4m | -37.6% | 0.0% | 379.2 |
| Baxter R and D Europe Lessines | €58.8m | 6.0% | 57.9% | 178.3 |
| VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY Ghent | €52.6m | 19.9% | 53.3% | 928.4 |
| ABLYNX Ghent | €147.9m | -2.4% | 86.1% | 363.5 |
| BIOCARTIS Mechelen | €48.2m | -45.6% | 60.2% | 205.6 |
| DIAGENODE Seraing | €11.9m | -21.2% | 41.3% | 100.5 |
| Enovalife Evere | €25.2m | 16.5% | 36.3% | 155 |
Grey: the largest companies of the sector (research and development (NACE 72)), without their names. Blue: the sector peers from the table.
These companies have the same main activity as KANEKA EUROGENTEC: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €21m and €417m, founded between 1979 and 2013.
Official details
Source: KBO- Status
- Active since 18-05-1985Normal situation
- Activity
- Research and development on biotechnologyNACE 72101and 4 others
- Joint committee
- 207White-collar workers in the chemical industry · annual accounts 31-03-2026
- Establishment units
- 2.027.405.7104102 Seraing, since 01-10-1985
- 2.137.656.2074102 Seraing, since 01-08-2003and 1 other
- Financial year end
- 31 March
- Peppol
- Reachable since 11-12-2025
Annual accounts to 31-03-2026
- Total assets
- €115.4m▼ 8.5%
- Employeeson 31-03-2026
- 383▼ 6.1%
- Filing
- Filed on 17-07-2026, 106 days before the end of the filing period
Companies linked to KANEKA EUROGENTEC
Subsidiaries and holdings
- THYMOLUX25.04%
Insights on KANEKA EUROGENTEC
KANEKA EUROGENTEC has existed since 1985. Turnover grew from €30.2m in 2007 to €49.4m in 2026 and staff from 228.3 to 379.2 full-time equivalents.
Turnover has fallen every year since 2023. Solvency fell in 2026 from 16.5% to 0.0% because of the loss and higher long-term debts.
Kaneka Europe Holding Company holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about KANEKA EUROGENTEC
- What is the company number of KANEKA EUROGENTEC?
- The company number of KANEKA EUROGENTEC is 0427.348.346. The VAT number is the same number with BE in front: BE 0427.348.346.
- Where is KANEKA EUROGENTEC based?
- The registered office is at Rue du Bois St-Jean 5, 4102 Seraing.Company details
- What does KANEKA EUROGENTEC do?
- According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
- What is the legal form of KANEKA EUROGENTEC?
- KANEKA EUROGENTEC is a public limited company (NV).
- When was KANEKA EUROGENTEC founded?
- KANEKA EUROGENTEC was founded on 18-05-1985.
- Is KANEKA EUROGENTEC still active?
- Yes, KANEKA EUROGENTEC is an active enterprise in the KBO register.
- How many employees does KANEKA EUROGENTEC have?
- KANEKA EUROGENTEC had an average of 379.2 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
- Which joint committee does KANEKA EUROGENTEC fall under?
- In its 31-03-2026 annual accounts, KANEKA EUROGENTEC states joint committee 207 (White-collar workers in the chemical industry).
- What is the turnover of KANEKA EUROGENTEC?
- The turnover of KANEKA EUROGENTEC was €49.4m in financial year 2026, according to the filed annual accounts.
- Is KANEKA EUROGENTEC profitable?
- In financial year 2026, KANEKA EUROGENTEC made a loss of €20.4m.
- Where can I find the annual accounts of KANEKA EUROGENTEC?
- KANEKA EUROGENTEC filed 59 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
- When are the next annual accounts of KANEKA EUROGENTEC due?
- KANEKA EUROGENTEC must file the annual accounts for financial year 2027 by 31-10-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies
See how customers, suppliers and banks see your own company and what to improve first.